Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
6.82
+0.41 (6.40%)
Nov 4, 2026, 4:00 PM EST - Market closed
Cartesian Therapeutics Employees
Cartesian Therapeutics had 75 employees as of December 31, 2025. The number of employees increased by 9 or 13.64% compared to the previous year. That makes Cartesian Therapeutics the 33,078th largest employer in the world and 4,347th in the United States.
Employees
75
Change (1Y)
9
Growth (1Y)
13.64%
Revenue / Employee
$19,693
Profits / Employee
-$2,025,213
Market Cap
206.34M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 75 | 9 | 13.64% | 75 | 0 |
| Dec 31, 2024 | 66 | 28 | 73.68% | 66 | 0 |
| Dec 31, 2023 | 38 | - | - | 37 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| ProQR Therapeutics | 187 |
| Inovio Pharmaceuticals | 112 |
| Zentalis Pharmaceuticals | 106 |
| BridgeBio Oncology Therapeutics | 88 |
| Compugen | 75 |
| Alpha Cognition | 71 |
| Precision BioSciences | 67 |
| Pyxis Oncology | 56 |
RNAC News
- 1 day ago - Cartesian Therapeutics Announces New Employment Inducement Grant - GlobeNewsWire
- 4 weeks ago - Cartesian Therapeutics Announces New Employment Inducement Grants - GlobeNewsWire
- 5 weeks ago - Cartesian Therapeutics announces positive retreatment data on Descartes-08 - TheFly
- 5 weeks ago - Cartesian Therapeutics Announces Additional Retreatment Data for Descartes-08 Highlighting Deep and Durable Responses in Patients with Myasthenia Gravis - GlobeNewsWire
- 2 months ago - Cartesian Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Cartesian Therapeutics Quarterly report: Q2 2026 - Filings
- 3 months ago - Cartesian Therapeutics Earnings release: Q2 2026 - Filings